Literature DB >> 27319342

CD4(+) T-cell help amplifies innate signals for primary CD8(+) T-cell immunity.

Sammy Bedoui1, William R Heath1,2, Scott N Mueller1,2.   

Abstract

CD8(+) T cells provide an important component of protection against intracellular infections and cancer. Immune responses by these T cells involve a primary phase of effector expansion and differentiation, followed by a contraction phase leading to memory formation and, if antigen is re-encountered, a secondary expansion phase with more rapid differentiation. Both primary and secondary phases of CD8(+) T-cell immunity have been shown to depend on CD4(+) T-cell help, although during certain infections the primary phase is variable in this requirement. One explanation for such variability relates to the strength of associated inflammatory signals, with weak signals requiring help. Here, we focus on our studies that have dissected the requirements for help in the primary phase of the CTL response to herpes simplex virus, elucidating intricate interactions and communications between CD4(+) T cells, various dendritic cell subsets, and CD8(+) T cells. We place our studies in the context of others and describe a simple model of help where CD40 signaling amplifies innate signals to enable efficient CD8(+) T-cell expansion and differentiation. This model facilitates CTL induction to various different agents, without altering the qualitative innate signals that direct other important arms of immunity.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cell activation; costimulation, CD40; cytotoxic T cells; dendritic cells; helper T cells

Mesh:

Substances:

Year:  2016        PMID: 27319342     DOI: 10.1111/imr.12426

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  31 in total

1.  HPV 16 E5 oncoprotein is expressed in early stage carcinogenesis and can be a target of immunotherapy.

Authors:  Francesca Paolini; Gianfranca Curzio; Marcelo Nazario Cordeiro; Silvia Massa; Luciano Mariani; Fulvia Pimpinelli; Antonio Carlos de Freitas; Rosella Franconi; Aldo Venuti
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

Review 2.  CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.

Authors:  Andrea J Sant; Anthony T DiPiazza; Jennifer L Nayak; Ajitanuj Rattan; Katherine A Richards
Journal:  Immunol Rev       Date:  2018-07       Impact factor: 12.988

Review 3.  Immune cell modulation of oligodendrocyte lineage cells.

Authors:  Emily P Harrington; Dwight E Bergles; Peter A Calabresi
Journal:  Neurosci Lett       Date:  2019-11-03       Impact factor: 3.046

4.  Inflammatory response under zinc deficiency is exacerbated by dysfunction of the T helper type 2 lymphocyte-M2 macrophage pathway.

Authors:  Takamasa Kido; Kenji Ishiwata; Machi Suka; Hiroyuki Yanagisawa
Journal:  Immunology       Date:  2019-01-21       Impact factor: 7.397

5.  Broadly neutralizing antibody-derived CAR T cells reduce viral reservoir in individuals infected with HIV-1.

Authors:  Bingfeng Liu; Wanying Zhang; Baijin Xia; Shuliang Jing; Yingying Du; Fan Zou; Rong Li; Lijuan Lu; Shaozhen Chen; Yonghong Li; Qifei Hu; Yingtong Lin; Yiwen Zhang; Zhangping He; Xu Zhang; Xiejie Chen; Tao Peng; Xiaoping Tang; Weiping Cai; Ting Pan; Linghua Li; Hui Zhang
Journal:  J Clin Invest       Date:  2021-10-01       Impact factor: 14.808

Review 6.  Breast cancer vaccines for treatment and prevention.

Authors:  Mary L Disis; Denise L Cecil
Journal:  Breast Cancer Res Treat       Date:  2021-11-30       Impact factor: 4.872

7.  Type I IFN Sensing by cDCs and CD4+ T Cell Help Are Both Requisite for Cross-Priming of AAV Capsid-Specific CD8+ T Cells.

Authors:  Jamie L Shirley; Geoffrey D Keeler; Alexandra Sherman; Irene Zolotukhin; David M Markusic; Brad E Hoffman; Laurence M Morel; Mark A Wallet; Cox Terhorst; Roland W Herzog
Journal:  Mol Ther       Date:  2019-11-15       Impact factor: 11.454

8.  Rapid Generation of Sustainable HER2-specific T-cell Immunity in Patients with HER2 Breast Cancer using a Degenerate HLA Class II Epitope Vaccine.

Authors:  Keith L Knutson; Matthew S Block; Nadine Norton; Courtney L Erskine; Timothy J Hobday; Allan B Dietz; Douglas Padley; Michael P Gustafson; Danell Puglisi-Knutson; Toni Kay Mangskau; Saranya Chumsri; Amylou C Dueck; Lavakumar Karyampudi; Glynn Wilson; Amy C Degnim
Journal:  Clin Cancer Res       Date:  2019-11-22       Impact factor: 12.531

9.  In Vitro and In Vivo Assessment of FK506 Analogs as Novel Antifungal Drug Candidates.

Authors:  Yeonseon Lee; Kyung-Tae Lee; Soo Jung Lee; Ji Yoon Beom; Areum Hwangbo; Jin A Jung; Myoung Chong Song; Young Ji Yoo; Sang Hyeon Kang; Anna F Averette; Joseph Heitman; Yeo Joon Yoon; Eunji Cheong; Yong-Sun Bahn
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

10.  BATF3 programs CD8+ T cell memory.

Authors:  Marco A Ataide; Karl Komander; Konrad Knöpper; Annika E Peters; Hao Wu; Sarah Eickhoff; Tea Gogishvili; Justus Weber; Anika Grafen; Axel Kallies; Natalio Garbi; Hermann Einsele; Michael Hudecek; Georg Gasteiger; Michael Hölzel; Martin Vaeth; Wolfgang Kastenmüller
Journal:  Nat Immunol       Date:  2020-09-28       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.